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We have determined partial N-terminal sequences of acetylcholinesterase (AChE) catalytic subnunits from 
Torpedo marmorata electric organs and from bovine caudate nucleus. We obtain identical sequences (23 
amino acids) for the soluble (‘low-salt-soluble’ or LSS fraction) and particulate (‘detergent-soluble’, or DS 
fraction) amphiphilic dimers (G2 form) and for the asymmetric, collagen-tailed forms (‘high-salt-soluble’, 
or HSS fraction, Ai2 + As forms). There are two amino acid differences, at position 3 (Asp/His) and 20 
(Ile/Val), with the sequences obtained for T. californica by MacPhee-Quigley et al. [(1985) J. Biol. Chem. 
260, 12185-121891 for the soluble G2 form and the lytic Gd form which is derived from asymmetric AChE. 
The bovine sequence (12 amino acids) presents an identity of 4 amino acids (Glu-Leu-Leu-Val) with that 
of Torpedo, at positions 5-8 (Torpedo) and 7-10 (bovine). There is also a clear homology with the sequence 
of human butyrylcholinesterase [(1986) Lockridge et al. J. Biol. Chem., in press] indicating that these en- 
zymes probably derive from a common ancestor. 
Acetylcholinesterase N-terminal sequence Molecular form (Torpedo, Bovine brain) 
1. INTRODUCTION 
Two distinct cholinesterases, acetylcholinester- 
ase (AChE, EC 3.1.1.7) and butyrylcholinesterase, 
or pseudocholinesterase (BuChE, EC 3.1.1.8), ap- 
pear to coexist in every vertebrate species and may 
be distinguished on the basis of their specificity 
towards substrates and inhibitors. For example, 
acetylcholinesterases are defined by the fact that 
they hydrolyze acetylcholine faster than its 
analogs, propionylcholine and butyrylcholine, but 
its catalytic turnover varies considerably: 4.4, 1.64, 
1.32 and 1.05 x 10’ mol acetylthiocholine 
hydrolyzed/h per site at 28”C, and pH 7, respec- 
tively, in Electrophorus, Torpedo, rat and chicken 
VI. 
The properties of butyrylcholinesterase appear 
even more variable among vertebrate species, since 
the preferred substrate of this enzyme may be 
butyrylcholine, as in man, propionylcholine, as in 
rat [2], or acetylcholine, as in Torpedo [3]. The on- 
ly constant distinctive feature of this enzyme seems 
to be that BuChE hydrolyzes butyrylcholine at a 
rate at least similar to that of acetylcholine, while 
AChE does not hydrolyze this substrate, or only 
very poorly so. 
Both AChE and BuChE present a multiplicity of 
molecular forms [3-61. Each enzyme possesses 
both globular and collagen-tailed forms which ap- 
pear to be catalytically equivalent [ 1,7]. A com- 
parison of their macromolecular characteristics 
showed that the sets of molecular forms of all 
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vertebrates cholinesterases are based on the same 
types of quaternary structures. For this reason, we 
have found it useful to propose a nomenclature 
that expresses this overall quaternary structure 
homology between the globular forms (Gi, Gz, G4) 
and asymmetric, or collagen-tailed forms (&, As, 
Aiz), although individual molecules may be very 
different from one enzyme to another. Within a 
given species, the sedimentation coefficients of 
homologous AChE and BuChE forms are general- 
ly slightly different. Large differences are observed 
between the sedimentation coefficient of a given 
form in different species: for example Ai2 AChE 
sediments at 16-17 S in mammals, 18.4 S in Elec- 
trophorus and 20 S in chicken. 
There is extensive immunological cross- 
reactivity between AChE from different mam- 
malian species but this does not extend to other 
vertebrates. No cross-reactivity has ever been 
demonstrated between AChE and BuChE, even in 
the case of Torpedo, although the catalytical 
characteristics of the two enzymes appear to be less 
different in this rather primitive cartilaginous fish 
than in other species [3]. 
The similarity of quaternary structures strongly 
suggests that all vertebrate AChE and BuChE 
derive from a common ancestor, and it is impor- 
tant to evaluate the degree of homology between 
the peptide sequences of these enzymes. This is 
necessary for example to assess the possibility that 
DNA probes obtained for one enzyme may 
hybridize with coding sequences for the other 
cholinesterase from the same organism, or 
cholinesterases of other species. It will also be 
essential, in an analysis of coding sequences, to 
determine the terminal peptide sequences of the en- 
zymes catalytic subunits. We have therefore deter- 
mined partial N-terminal sequences of AChE from 
Torpedo electric organ and from calf brain. 
2. MATERIALS AND METHODS 
2.1. Purification of calf brain AChE 
AChE was purified by affinity chromatography 
as in [8] from a detergent extract of bovine caudate 
nucleus [9]. The preparation used for sequence 
analyses has been described in detail by Marsh and 
Massoulie [lo]. 
2.2. Solubilization of AChE from Torpedo 
electric ogans 
AChE was solubilized sequentially in a low-salt- 
soluble (LSS) fraction, detergent-soluble (DS) 
fraction and a high-salt-soluble (HSS) fraction 
[ 111. The total AChE activity recovered varied be- 
tween 4000 and 6000 Ellman units/g electric organ. 
Higher values were observed in males than in 
females. The LSS fraction contained 5-15% of the 
total activity, the DS fraction about 50% and the 
HSS fraction (asymmetric forms) 20-40010. 
In practice, frozen tissue was stored at - 80°C. 
It was cut into small dice (about 1 cm3), and 
homogenized in the cold with 5 vols buffer A 
(40 mM MgC12, 10 mM Tris-HCl, pH 7) for 2 min 
at maximal speed in a Polytron homogenizer. The 
presence of 40 mM MgCL prevented partial 
solubilization of asymmetric forms at this stage 
[l 11. The homogenate was then centrifuged for 3 h 
at 17000 rpm in a Beckman RI9 rotor. A total ac- 
tivity of about 450 U/g tissue was recovered in the 
supernatant (LSS fraction). 
The pellet was extracted a second time in the 
same volume of buffer A, and centrifuged in the 
same manner. The second supernatant was 
discarded; its activity was about l/10 that of the 
first LSS fraction. The pellet was resuspended 
again in the same volume of buffer A; Triton 
X-100 was then added to a concentration of 2% 
and mixed with the Polytron, at low speed to avoid 
excessive foaming. The mixture was maintained 
for 30 min at 4”C, and centrifuged for 1 h at 
45000 rpm in a 5OTi rotor. The supernatant (frac- 
tion DS) contained an activity of about 300 U/g. 
The pellet was homogenized yet another time in 
buffer A, in order to eliminate the remaining 
detergent-soluble G2 AChE, but without adding 
Triton X-100. After centrifugation, the superna- 
tant, which contained about 500 U/g, was discard- 
ed. The pellet could be stored frozen. It was 
reextracted in a high salt buffer (buffer B: 2 M 
MgC12, 10 mM Tris-HCl, pH 7). The supernatant 
recovered after centrifugation for 1 h at 
45000 rpm, in a 50Ti rotor, contained about 
2000 U/g. The solubilized A forms were found to 
inactivate in buffer B. This fraction was therefore 
dialyzed in several steps against 0.8 M NaCl, 
10 mM Tris-HCl, pH 7. A flocculate formed dur- 
ing dialysis and contained some of the enzyme; it 
was removed by centrifugation at 17000 rpm in an 
R19 rotor and discarded. 
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2.3. Affinity chromatography of AChE on 
N-methylacridinium-Sepharose 
N-Methylacridinium-Sepharose (N-MAC- 
Sepharose) was prepared as described in [S] at a 
ligand concentration of 0.25-0.5 pmol/ml gel. For 
routine purification of Torpedo AChE, we used 
200-ml columns washed in 0.5 M guanidine-HCl, 
10 mM Tris, pH 7, before equilibration. Both LSS 
and DS fractions (containing G2 AChE) were ad- 
justed to 10 mM Tris-HCl, pH 7, and 0.5% Triton 
X-100. The HSS fraction was dialyzed against 
0.8 M NaCl and diluted to bring the salt concen- 
tration down to 0.2 M NaCl. 
A volume of extract containing about 
7000 U/ml gel was loaded on the column, at a rate 
of 1 column vol./h. Under these conditions, ap- 
prox. 70% of the activity was retained (a higher 
fraction could be adsorbed at a slower flow rate). 
In the case of the LSS or DS fraction the column 
was then washed with 3 vols of buffer containing 
1% Triton X-100, 1 vol. of buffer without 
detergent, 3 vols of buffer with 0.4 M NaCl. 
Essentially no activity was lost during washing. 
The enzyme was eluted in the presence of 1% 
Triton X-100, 10 mM decamethonium bromide 
and 0.4 M tetraethylammonium bromide, at a rate 
of less than 0.1 column vol./h. In these conditions, 
about 50% of the bound activity (i.e. about 
2500 U/ml gel) was eluted in about 1 column vol. 
The asymmetric forms (HSS fraction) were 
chromatographed in the same manner, except that 
the fixation buffer contained 0.2 M NaCl, 50 mM 
MgCl2 and that the elution buffer contained 0.6 M 
NaCl, 1% Triton X-100, 0.4 M triethylammonium 
bromide and 10 mM decamethonium bromide. 
The purified fractions were usually subjected to 
a second chromatography according to the same 
procedure, after extensive dialysis to remove 
decamethonium and tetraethylammonium. In that 
case, the totality of the enzyme was bound to the 
column, and about 50-60% was eluted by the 
specific ligands. 
After chromatography, we performed an isopyc- 
nit equilibration in a CsCl gradient, to remove the 
bulk of Triton X-100, and to concentrate the en- 
zyme. We dissolved 35 g CsCl in 100 ml enzyme 
solution, and centrifuged for 5 days at 47000 rpm 
in a 50Ti rotor, at 10°C. The gradients were col- 
lected, and after assaying AChE activity, the frac- 
tions corresponding to the peak of activity were 
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pooled, and centrifuged again for 80 h at 
47000 rpm in an SW 60 rotor, at 10°C. 
The concentrated enzyme fractions were stored 
at -80°C. Before use, they were dialyzed to 
remove CsCl and remaining traces of decametho- 
nium and tetraethylammonium. We found that 
hydrophobic aggregates formed during the isopyc- 
nit equilibration in CsCl. To analyze the purified 
molecular forms or to isolate pure GZ AChE in 
sucrose gradients, we therefore added 3% Triton 
X-100 to the samples before centrifugation. 
From LSS and DS extracts, we obtained ex- 
clusively Gz AChE, and about 70% A12 + 30% As 
from HSS extracts. 
2.4. Treatment with endoglycosidase F 
The purified enzymes were incubated for 7 h at 
37°C with 25 U/ml endoglycosidase F (NEN) in 
100 mM Na acetate, pH 6.2, 50 mM EDTA, 1% 
Nonidet NP40, 0.1% SDS, 1% 2-mercaptoeth- 
anol. Control samples were incubated under iden- 
tical conditions in the same medium. Control and 
treated samples were analyzed after complete 
denaturation and reduction at 90°C for 10 min 
(1% SDS, 80 mM DTT) by polyacrylamide gel 
electrophoresis according to Weber and Osborn 
[ 121 or Laemmli [ 131, in an LKB vertical slab gel 
apparatus. A4, standards were obtained from LKB. 
2.5. Amino acid sequence analyses 
Automated Edman degradation was performed 
in a gas-phase sequenator (Applied Biosystems 
model 47OA, Foster City, CA) [14,15]. We used a 
standard degradation program and phenylthio- 
hydantoin derivatives of amino acids were iden- 
tified by HPLC on-line by absorption at 270 nm 
(Applied Biosystems model 120A). 
3. RESULTS AND DISCUSSION 
3.1. Characterization of the catalytic subunits of 
Torpedo asymmetric and globular forms; 
effect of deglycosylation 
When characterized by sucrose gradient 
sedimentation, AChE purified from the LSS and 
DS fractions from Torpedo electric organs was 
found to correspond exclusively to the amphiphilic 
G2 form, sedimenting at 6 S in the presence of 
Triton X-100. The enzyme purified from the HSS 
fraction contained about 70% Ai2 form and 30% 
A8 form. 
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Fig. 1. Comparison of the catalytic subunits of globular 
and asymmetric forms of Torpedo AChE. The catalytic 
subunits were labelled with [‘HJDFP before 
electrophoresis. The gels were stained with Coomassie 
brilliant blue (A) and exposed for autoradiography (B). 
Lanes: lA,lB, soluble Gz form (LSS fraction); 2A,2B, 
detergent-soluble Gz form (DS fraction); 3A,3B, 
asymmetric forms (HSS fraction). 
As shown in fig. 1, the reduced catalytic subunits 
of AChE purified from the LSS, DS and HSS frac- 
tions were analyzed by SDS-polyacrylamide gel 
electrophoresis. They were stained by Coomassie 
brilliant blue and also identified by autoradio- 
graphy after labeling with [3H]DFP, or by immu- 
nolabelling with a monoclonal antibody (mAb 
MES) directed against Torpedo AChE (Musset et 
al., in preparation). The apparent masses of the Gz 
forms from the LSS and DS fractions were in- 
distinguishable (67 kDa), but clearly different 
from that of the asymmetric forms (72 kDa). This 
difference between the catalytic subunits of 
globular and asymmetric forms is in good agree- 
ment with previous observations on T. californica 
[16,171, T. marmorata [l&20] and Narke 
japonica [21,22]. 
In the absence of reduction, we observed mostly 
dimers (about 140 kDa) for the Gz form. In the 
case of the A forms, we observed dimers and 
heavier components which did not penetrate the 
separation gel. We also found a small proportion 
of monomers. The apparent molecular mass of 
these non-reduced monomers was similar to that of 
bovine serum albumin. After complete reduction 
the apparent molecular mass of Gz monomers re- 
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Fig.2. Effect of reduction on the electrophoretic 
mobility of the catalytic subunit of asymmetric AChE 
from Torpedo. Lane M: molecular mass standards ,& 
galactosidase (116 kDa), phosphorylase b (92 kDa), 
bovine serum albumin (69 kDa), catalase (56 kDa). The 
preparation of asymmetric AChE was analyzed without 
reduction (nR) or after complete reduction (R), as 
indicated in the text; the protein bands were stained with 
Coomassie brilliant blue. In the reduced sample, most of 
the protein corresponds to the monomeric catalytic 
subunit, with some ‘100 kDa’ subunit, dimer and 
heavier components; the tail peptides are barely 
detectable. In the absence of reduction, a small 
proportion of catalytic monomer and dimer is visible, 
while most of the protein did not enter the gel. 
mained at 67 kDa but that of A monomers was in- 
creased to 72 kDa. This difference between the 
reduced and non-reduced asymmetric subunits 
(fig.2) is probably due to intra-subunit disulfide 
bonds, which maintain a compact structure in the 
absence of reduction, as observed for a number of 
proteins such as serum albumin. 
After reduction, it is possible to detect minor 
polypeptide components in the asymmetric forms, 
around 100 and 40 kDa. They clearly correspond 
to the structural subunit that has been described in 
the case of T. californica [22,23] and to the col- 
lagenic tail peptides. They were not labeled by 
[3H]DFP. The proportions of these structural 
subunits relative to the catalytic subunits were 
variable in different preparations, possibly because 
of their high sensitivity to proteolytic degradation 
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[23]. The relative abundance of the 100 kDa 
subunit also appears to vary between different 
Torpedinid species, as observed by Sakai and his 
colleagues [24] in the case of T. californica and N. 
japonica. 
Under denaturing conditions, endoglycosidase F 
cleaves the N-linked polysaccharides of both com- 
plex and high mannose types, leaving only the in- 
ternal N-acetylglucosamine attached to asparagine 
[25]. After such treatment, the apparent molecular 
masses were decreased by approx. 8 kDa for both 
the globular and asymmetric subunits, so that their 
difference was maintained (fig.3). 
3.2. N-terminal sequences 
Bovine AChE, purified from caudate nuclei, 
was found to be homogeneous, by polyacrylamide 
gel electrophoresis, with a subunit of 70 kDa [lo]. 
We also found a major type of subunit in the case 
of Gz AChE from Torpedo. In the case of the A 
forms, the structural 100 kDa and tail subunits 
were minor components. For sequence analyses, 
we used either the purified enzyme as such, or we 
1A 1B 2A 28 3A 38 
116 kD + 
92 kD - 
69 kD + 
56 kD + 
--- 
G2 (LSS) G2 (DS) A 
Fig.3. Effect of deglycosylation byendoglycosidase F on 
the apparent molecular mass of AChE catalytic subunits 
from Torpedo. The samples were incubated with or 
without endoglycosidase F (see section 2) before 
electrophoresis. (A) Controls, (B) deglycosylated. 
Lanes: lA,lB, soluble G2 form (LSS fraction); 2A,2B, 
detergent-soluble Gz form (DS fraction); 3A,3B, 
asymmetric forms (HSS fraction). The gels were stained 
with Coomassie brilliant blue. 
performed a separation of polypeptides by HPLC 
(in 75 x 600 mm TSK G4OOOSW + TSK G3OOOSW 
columns), in denaturing conditions. The results 
were identical in several runs. 
The N-terminal sequences obtained are given in 
fig.4, together with similar data for T. californica 
AChE [26] and human butyrylcholinesterase [27]. 
Although analyses of proteolytic peptides sug- 
gested differences in the primary sequence of 
catalytic subunits from amphiphilic globular and 
from asymmetric forms [28,29], MacPhee-Quigley 
et al. [26] obtained an identical N-terminal se- 
quence for the soluble Gz form and for the lytic Gq 
form derived from asymmetric AChE, in the case 
of T. californica. We find that this identity is in 
fact valid for the soluble and detergent-soluble GZ 
forms and for the native asymmetric forms of T. 
marmorata. It is interesting that the two species 
differ at positions 3 (His/Asp) and 20 (Val/Ile). 
There is a clear homology between Torpedo 
AChE, bovine AChE, human AChE and BuChE, 
and even Drosophila AChE, particularly when tak- 
ing into account conservative amino acid substitu- 
tions. In particular, there is a complete coincidence 
between the 5-8 sequence of Torpedo AChE and 
the 7-10 sequence of bovine AChE and a similar 
peptide sequence is also present in the N-terminal 
sequence of human serum BuChE [27]. 
A six amino acid sequence that contains the ac- 
tive site serine, Phe-Gly-Glu-Ser-Ala-Gly, seems to 
be entirely conserved in all cholinesterases: it ap- 
pears at position 197-202 in Torpedo AChE 
[26,30] and 195-200 in human serum BuChE 
[31,32]. It is identical in BuChE from horse [33] as 
well as AChE from Drosophila (Hall and Spierer, 
in preparation). This sequence is clearly exposed to 
a strong conservative pressure because it is directly 
involved in the catalytic activity of the enzyme. 
There is no obvious reason however to expect an 
equivalent restriction on variations of the N- 
terminal sequences. The homology that we ob- 
served suggests therefore very strongly that all 
cholinesterases are closely related proteins, 
originating from a single ancestor. Considering 
their lack of immunological cross-reactivity, it is 
extremely likely that, in a given organism, AChE 
and BuChE are encoded by distinct genes. 
However, the question remains as to whether the 
multiple molecular forms of each enzyme corre- 
spond to a set of closely similar genes, or are 
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T. marnurata AChE' 
T. callfornlca AChE' 
Bovine AChE' (ASP, Ala) 
Human erythmcyte AChE' (Glu, Arg) 
Human serum BuChE4 
Drosophila AChE' V.31 Gly Val Ile Asp 
Fig.4. N-terminal sequence of the catalytic subunit of AChE from T. murmorata electric organs and bovine caudate 
nucleus; comparison with other cholinesterases. The different sequences are arranged so as to bring homologous amino 
acids in register. The amino acids which belong to the same category (acidic, basic, uncharged polar or apolar) in at 
least three different sequences are shown in bold type, in light shaded areas for conservative changes and dark shaded 
areas for identical amino acids. The asterisks at positions 3 and 20 of Torpedo AChE indicate differences between T. 
marmorata and T. californica. The bold-face dot indicates a glycosylated Asn residue in human BuChE. (1) Sequences 
obtained in this study; we obtained identical sequences for the soluble and detergent-soluble fractions of GZ forms and 
for the asymmetric forms. We could not resolve the first amino acid of bovine AChE. (2) Sequence obtained by 
MacPhee-Quigley et al. [26] for the soluble Gz form and for the lytic Gd form (derived from asymmetric forms) of T. 
californicu, and from cDNA analysis by Schumacher et al. [30]. (3) From [34], human erythrocyte AChE was found 
to contain two N-terminal amino acids with stoichiometries of 0.66 (Glu) and 0.34 (Arg). (4) From [27,31]. (5) From 
Hall and Spierer (in preparation). This sequence was determined from cDNA analysis and is shown here from position 
32 after the presumed initiation codon. 
generated from a single gene, through the opera- 
tions of differential splicing and post- 
transcriptional modifications. Recent results ob- 
tained in our laboratory by Southern blot analysis 
of a genomic Torpedo library with an AChE 
cDNA probe argue in favour of the second 
hypothesis (Sikorav et al., in preparation). 
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